For localized information and support, would you like to switch to your country-specific website for {0}?
European Congress of Pathology (ECP)
37th European Congress of Pathology (ECP) 2025
6 - 10 September 2025
Vienna, Austria
ECP is the worldwide leading congress in pathology. This year’s theme, “Tradition meets future” showcases how pathology research is fueling vital advancements in diagnostics and clinical practice, creating the foundation for targeted therapies that are revolutionizing cancer and chronic disease care. ECP 2025 is dedicated to providing up-to-date insights into the whole spectrum of modern diagnostics, translational tools and achievements that characterise pathology and its contribution to innovative diagnostics. Roche, as a global leader in oncology, personalised healthcare and companion diagnostics, is a long-standing partner of the pathology community and a premium sponsor for this year’s meeting.
Our immersive booth is a fantastic opportunity to meet our colleagues and explore how Roche is innovating and collaborating to drive diagnostic certainty for life-changing decisions across many cancers. We look forward to hosting several activities at ECP 2025 including Roche- sponsored educational symposia, in-booth talks and much more. Please sign up to receive additional details as they are available, or check back here.
Together, let's continue advancing science and breaking down barriers to advance the practice of pathology, as we aim to provide attendees with opportunities to engage with our multifaceted program.
Roche expert sessions
We will be hosting six booth talks at ECP 2025, providing you with an opportunity to engage with key opinion leaders and some of our pharmaceutical partners to hear their experiences and perspectives in precision diagnosis, and whose therapeutic advancements are helping fuel our pipeline of innovative high medical value assays and AI-based clinical decision support solutions.

Symposium
Tuesday, 9 September 2025
Roche lunch symposium
Expanding therapeutic options in gastric cancer: FGFR2b and the emerging testing landscape
Collaborate, learn, lead: Advancing gastric cancer diagnostics together. Join a dynamic session designed specifically for pathologists seeking to master the latest in gastric cancer testing and treatment. Partner with leading oncologists and pathologists to explore the evolving treatment landscape and the critical role of biomarkers including FGFR2b, CLDN18, and PD-L1 with TAP scoring. Gain practical guidance on sequencing and IHC interpretation, and delve into the implications of trials like FORTITUDE-101. Participate in a stimulating panel discussion with Q&A, and shape the future of gastric cancer care.
Speakers:
Dr Mar Iglesias, Hospital Del Mar in Barcelona
Pr Manuel Rodriquez-Justo, UCL in London
Dr Kai-Keen Shiu, UCL in London

Roche Booth
6 - 10 September 2025
Vienna, Austria
Agenda to follow
As a global leader in companion diagnostics, we passionately believe that precision medicine has the power to radically transform lives. Throughout each patient’s cancer journey, diagnostic testing plays a critical role in supporting clinicians in making decisions that can lead to better outcomes.
Our exhibition this year will focus on highlighting high medical value innovations that help pathologists deliver the answers clinicians rely on to provide the highest standard of care. Roche medical and product experts will be on hand to discuss our portfolio across the pathology and molecular work areas.
Booth talks will also offer an opportunity to engage with some of our pharmaceutical partners whose therapeutic advancements are helping fuel our pipeline of innovative high medical value assays and AI-based clinical decision support solutions.
Sign up here to receive updates and exclusive content access
Complete this form to stay up to date with all things to do with Roche at ECP 2025 and beyond.
By signing up, you will gain access to our virtual event webpage, where you can explore recordings of our symposia and in-booth talks.
(Catch up on all the content Roche delivered at ECP 2024! )